Evidence map›Paper›PMID 25463537›Full record

ArticleJournal of hepatology2015

Endoplasmic reticulum heat shock protein gp96 maintains liver homeostasis and promotes hepatocellular carcinogenesis.

Saleh Rachidi, Shaoli Sun, Bill X Wu, Elizabeth Jones, Richard R Drake, Besim Ogretmen, L Ashley Cowart, Christopher J Clarke, Yusuf A Hannun, Gabriela Chiosis and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Saleh RachidiDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, United States; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States.
Shaoli SunDepartment of Pathology, Medical University of South Carolina, Charleston, SC, United States.
Bill X WuDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, United States; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States.
Elizabeth JonesDepartment of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC, United States.
Richard R DrakeDepartment of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC, United States.
Besim OgretmenDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, United States.
L Ashley CowartDepartment of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, United States; Ralph H. Johnson Veteran's Affairs Medical Center, Charleston, SC, United States.
Christopher J ClarkeDepartment of Medicine, Stony Brook University, Stony Brook, NY, United States.
Yusuf A HannunDepartment of Medicine, Stony Brook University, Stony Brook, NY, United States.
Gabriela ChiosisProgram in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, NY, United States.
Bei LiuDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, United States; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States.
Zihai LiDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, United States; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States. Electronic address: zihai@musc.edu.
Medical University of South Carolina · USMUSC Hollings Cancer Center · USStony Brook University · USMemorial Sloan Kettering Cancer Center · USRalph H. Johnson VA Medical Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
Sphingolipids in Cancer Therapy and AngiogenesisP01CA097132 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI Daniel Canals · 2003 to 2026
$30.8M
THE ROLE OF LACTOSYLCERAMIDE IN RENAL AGING AND DISEASEP20RR017677 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CROSSON, CRAIG E. · 2002 to 2011
$23.4M
Project 3: Structural Basis for grp94 Drug Development and Chaperone FunctionP01CA186866 · NCI · OHIO STATE UNIVERSITY · PI GEWIRTH, DANIEL T · 2015 to 2019
$6.7M
Roles and Mechanisms of gp96 in Chaperoning Innate ImmunityR01AI070603 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LI, ZIHAI · 2007 to 2016
$3.8M
Molecular chaperones and immune toleranceR01AI077283 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LI, ZIHAI · 2009 to 2021
$3.7M
Biomarkers for predicting response to Hsp90 therapyR01CA172546 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA, DUNPHY, MARK P. · 2013 to 2017
$2.9M
Sphingolipids in Diabetic CardiomyopathyR01HL117233 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI COWART, LAUREN ASHLEY · 2014 to 2018
$1.9M
Design, synthesis and evaluation of selective Grp94 inhibitorsR21AI090501 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI CHIOSIS, GABRIELA · 2010 to 2011
$460k
BLRD VA I01 BX000200NCI NIH HHS CA97132NCI NIH HHS P01 CA097132NCI NIH HHS P01 CA186866NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA172546NCRR NIH HHS P20 RR017677NHLBI NIH HHS R01 HL117233NIAID NIH HHS AI070603NIAID NIH HHS AI077283NIAID NIH HHS R01 AI070603NIAID NIH HHS R01 AI077283NIAID NIH HHS R21 AI090501
6 · The paper itself

Abstract

BACKGROUND &

aimsgp96, or grp94, is an endoplasmic reticulum (ER)-localized heat shock protein 90 paralog that acts as a protein chaperone and plays an important role for example in ER homeostasis, ER stress, Wnt and integrin signaling, and calcium homeostasis, which are vital processes in oncogenesis. However, the cancer-intrinsic function of gp96 remains controversial.

methodsWe studied the roles of gp96 in liver biology in mice via an Albumin promoter-driven Cre recombinase-mediated disruption of gp96 gene, hsp90b1. The impact of gp96 status on hepatic carcinogenesis in response to diethyl-nitrosoamine (DENA) was probed. The roles of gp96 on human hepatocellular carcinoma cells (HCC) were also examined pharmacologically with a targeted gp96 inhibitor.

resultsWe demonstrated that gp96 maintains liver development and hepatocyte function in vivo, and its loss genetically promotes adaptive accumulation of long chain ceramides, accompanied by steatotic regeneration of residual gp96+ hepatocytes. The need for compensatory expansion of gp96+ cells in the gp96- background predisposes mice to develop carcinogen-induced hepatic hyperplasia and cancer from gp96+ but not gp96- hepatocytes. We also found that genetic and pharmacological inhibition of gp96 in human HCCs perturbed multiple growth signals, and attenuated proliferation and expansion.

conclusionsgp96 is a pro-oncogenic chaperone and an attractive therapeutic target for HCC.

Indexed as

CarcinogenesisAlkylating AgentsAnimalsCarcinoma, HepatocellularCell Line, TumorDiethylnitrosamineEndoplasmic ReticulumHeat-Shock ProteinsHumansLiverLiver NeoplasmsMembrane GlycoproteinsMiceModels, AnimalMolecular ChaperonesSignal TransductionAlkylating AgentsDiethylnitrosamineendoplasminHeat-Shock ProteinsMembrane GlycoproteinsMolecular Chaperonesgp96grp94Liver cancerMolecular chaperone

Identifiers

PMID25463537
PMCPMC4369194
OpenAlexW2099239409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.